Date Annoucement
15/12/2009 Notice of Ceasing to be a Substantial Holder
11/12/2009 Notice of Ceasing to be a Substantial Holder
11/12/2009 Notice of Change of Interest of Substantial Holder
08/12/2009 $3.63 Million Capital Raising Completed
23/11/2009 Appendix 3Y Change in Director’s Interest notice
20/11/2009 Appendix 3B New Issue
20/11/2009 Appendix 3Y Change in Director’s Interest notice
20/11/2009 Appendix 3Y Change in Director’s Interest notice
18/11/2009 Change of name to Cellmid Limited
17/11/2009 Results of Meeting
17/11/2009 Shareholder presentation
12/11/2009 Distribution agreement signed with Yamasa Corporation
29/10/2009 Appendix 4C Quarterly Report
29/10/2009 Lung Cancer Diagnostic License signed with Celera
15/10/2009 Notice of Meeting/Proxy Form
12/10/2009 Appointment of non-executive Director
12/10/2009 Appointment of non-executive Director
06/10/2009 Agreement signed with Kumamoto University
06/10/2009 Agreement signed with Kumamoto University
08/09/2009 Midkine combination test superior to conventional cancer markers
31/08/2009 Appendix 4E & Annual Financial Report
24/08/2009 Important European Patent Granted
03/08/2009 Shares released from escrow
30/07/2009 Appendix 4C Quarterly Report
30/07/2009 Notice of Change of Interest of Substantial Holder
22/07/2009 Notice of Change of Interest of Substantial Holder
07/07/2009 Appendix 3B New Issue
07/07/2009 Medical Therapies raised $550,000
30/06/2009 Appendix 3B New Issue
29/06/2009 Appendix 3Y Change in Director’s Interest notice
15/05/2009 Analyst Report and Interactive Roadshow Released
15/05/2009 Appendix 3B New Issue
15/05/2009 Change in Substantial Holding
13/05/2009 Appendix 3Y Change in Director’s Interest notice
08/05/2009 Appendix 3B New Issue
05/05/2009 EGM presentation
05/05/2009 Results of General Meeting
30/04/2009 Appendix 4C
21/04/2009 Changes to capital raising
17/04/2009 $700K Capital Raising Completed
02/04/2009 Notice of General Meeting
16/03/2009 Appendix 3B New Issue
04/03/2009 Notice of Initial Substantial Holder
27/02/2009 Appendix 4D and Half Year Accounts
23/02/2009 Appendix 3B New Issue
23/02/2009 Capital Raising Completed – Convertible Notes Satisfied
18/02/2009 Convertible Notes Resolved
09/02/2009 Removal of $1.5M potential liability
30/01/2009 Appendix 4C Quarterly Report

 

 

Shop évolis®